Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1996-10-28
1999-08-17
Prouty, Rebecca E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
4242391, 435220, 435842, 530350, 530402, 530412, 530825, 536 232, 536 237, 514 12, A61K 39385, A61K 3908, C12P 2106, C12N 952
Patent
active
059390700
ABSTRACT:
A hybrid botulinal neurotoxin is disclosed. In one embodiment, the neurotoxin comprises a combination of a botulinal neurotoxin heavy chain and light chain, wherein the light chain and heavy chain are not of the same serotype. A method for creating hybrid neurotoxins comprised of different functional domains is also disclosed.
REFERENCES:
patent: 5562907 (1996-10-01), Arnon
V. Ghetie and E. Vitetta, "Immunotoxins in the Therapy of Cancer: From Bench to Clinic," Pharma. Ther. 63:209-234, 1994.
J. Jankovic and M. Hallett, Therapy with Botulinum Toxin, Marcel Dekker, Inc., New York, NY, 1994. Table of Contents Only.
P. Moore, Handbook of Botulinum Toxin Treatment, Blackwell Science Inc., Osney Mean, Oxford, UK, 1995. Table of Contents Only.
Schiavo et al. (1990) Infection and Immunology 58, pp. 4136-4141.
Poulain et al. (1988) PNAS 85, 4090-4094.
Schantz et al. Microb. Rev. (1992) 56:80-99. "Properties and Uses of Botulinum Toxin and Other Microbialneurotoxins in Medicine".
Waller et al Neurosci Lett (1991) 122:132-134 "Cooperative Action of the Light Chain of Tetanus Toxin and the Heavy Chain . . . ".
Peeters et al (1989) J. Immunol. Meth. 120:133-143 "Comparison of Four Bifunctional Reagents for Coupling Peptides to Proteins and the Effect . . . ".
Humbleton et al (1992) Brit Med J 304:959-960. "Antitoxins and Botulinum Toxin . . . ".
Ludlow et al (1992) New Eng J. Med 326:349-350. "Therapeutic Use of Type F . . . ".
Bradshaw Marite
Goodnough Michael C.
Johnson Eric A.
Prouty Rebecca E.
Slobodyansky Elizabeth
Wisconsin Alumni Research Foundation
LandOfFree
Hybrid botulinal neurotoxins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid botulinal neurotoxins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid botulinal neurotoxins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-313009